<p><sup>a</sup> P shows statistical significance for two tailed t test.</p><p>Summary statistics for the sample.</p
<p>T1: 0–100 ms; T2:50–150 ms; T3:100–200 ms; T4: 150–250 ms; T5: 200–300 ms; T6: 250–350 ms; T7: 30...
<p>Summary statistics (untransformed) for the questionnaire measures used in Experiment 1.</p
<p>Summary of statistical results from the three-way ANOVAs for the behavioral measures in question....
<p><sup>a</sup>P shows statistical significance for two tailed t-test.</p><p>Summary statistics of t...
<p>@, The mean values presented in the previous two columns are compared using t-test.</p
<p>Summary of the statistical test with upper and lower bounds based on 95% confidence intervals.</p
Descriptive statistics, independent samples t-test results (two-tailed), and correlations between me...
<p>* P < 0.0001 (determined by two-tailed t tests)</p><p>Cdc10 FRAP summary statistics.</p
<p>Statistical tests applied and significances for the parameters investigated.</p
<p>Summary of the statistics of the comparison of pre and post omalizumab data points: Paired T-Test...
Descriptive statistics, independent samples t-test results (two-tailed), and correlations between me...
<p>Results of two sample <i>t</i>-test on scores of two groups of participants.</p
<p>Descriptive statistics for all the analyzed variables from the testing phase of the study (Mean ±...
<p>Results of post-hoc tests and effect size (ES) for each variable for each comparison at the two t...
Highlighted in blue, comparisons that produced statistically significant P-values. (XLSX)</p
<p>T1: 0–100 ms; T2:50–150 ms; T3:100–200 ms; T4: 150–250 ms; T5: 200–300 ms; T6: 250–350 ms; T7: 30...
<p>Summary statistics (untransformed) for the questionnaire measures used in Experiment 1.</p
<p>Summary of statistical results from the three-way ANOVAs for the behavioral measures in question....
<p><sup>a</sup>P shows statistical significance for two tailed t-test.</p><p>Summary statistics of t...
<p>@, The mean values presented in the previous two columns are compared using t-test.</p
<p>Summary of the statistical test with upper and lower bounds based on 95% confidence intervals.</p
Descriptive statistics, independent samples t-test results (two-tailed), and correlations between me...
<p>* P < 0.0001 (determined by two-tailed t tests)</p><p>Cdc10 FRAP summary statistics.</p
<p>Statistical tests applied and significances for the parameters investigated.</p
<p>Summary of the statistics of the comparison of pre and post omalizumab data points: Paired T-Test...
Descriptive statistics, independent samples t-test results (two-tailed), and correlations between me...
<p>Results of two sample <i>t</i>-test on scores of two groups of participants.</p
<p>Descriptive statistics for all the analyzed variables from the testing phase of the study (Mean ±...
<p>Results of post-hoc tests and effect size (ES) for each variable for each comparison at the two t...
Highlighted in blue, comparisons that produced statistically significant P-values. (XLSX)</p
<p>T1: 0–100 ms; T2:50–150 ms; T3:100–200 ms; T4: 150–250 ms; T5: 200–300 ms; T6: 250–350 ms; T7: 30...
<p>Summary statistics (untransformed) for the questionnaire measures used in Experiment 1.</p
<p>Summary of statistical results from the three-way ANOVAs for the behavioral measures in question....
DOI
Add to ORKG